BDI Pharma is opening a new distribution center in Irving, TX
Company handles distribution of 'niche' blood, chemotherapy and specialty products
BDI Pharma (Columbia, SC) is in the final stages of construction and licensing of a DC near the Dallas-Fort Worth airport, the better to serve its customers of immunoglobulin, albumin, vaccines, chemotherapy products and other specialty pharmaceuticals. The facility, the company’s second national DC, more than doubles its warehousing capacity and ultimately will manage 40% of its shipments, according to a company statement. There is also room for future expansion.
BDI Pharma provides basic wholesaling services as well as sales and marketing services for manufacturers and reimbursement services for patients, seeking to act as a commercialization extension of its biopharma suppliers.
Earlier this year, it expanded its cold-chain storage capacity and built new offices near its Columbia, SC headquarters; at that time it announced a 40% increase in sales over the previous year.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
July 18th 2025The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the role of social determinants and systemic inequities in shaping health outcomes.
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
July 16th 2025Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support production of Sanofi therapies and expand capacity for US-based pharma and biotech manufacturing.
